By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Blend Therapeutics 

134 Coolidge Avenue

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-923-4100 Fax: 617-923-4101



Drug Delivery

Company News
Blend Therapeutics Presents Preclinical Data For Lead Pentarin™ Program, BTP-277, Demonstrating Specific And Potent Tumor Cell Targeting For Small-Cell Lung Cancer 4/21/2015 11:10:07 AM
Blend Therapeutics Presents Preclinical Data For Lead Candidate BTP-114 That Demonstrated Superiority To Cisplatin In Tumor Growth Inhibition 4/21/2015 11:09:07 AM
Blend Therapeutics Appoints Drew Fromkin As President And Chief Executive Officer 4/13/2015 8:26:14 AM
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, To Board Of Directors 1/7/2015 9:59:10 AM
Retooled Blend Therapeutics Locks in $21 Million 1/7/2015 6:33:25 AM
Blend Therapeutics Appoints Richard Wooster, Ph.D., As Chief Scientific Officer 1/6/2014 6:53:24 AM
Blend Therapeutics Scientific Co-Founder Professor Robert Langer Awarded National Medal of Technology and Innovation 2/4/2013 12:00:39 PM
Blend Therapeutics Lands $16 Million, Names a CEO 12/18/2012 6:48:53 AM